SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-16-009861
Filing Date
2016-05-16
Accepted
2016-05-16 14:46:11
Documents
65
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 1394581
2 ex21-1.htm EX-21.1 4249
3 ex31-1.htm EX-31.1 16975
4 ex31-2.htm EX-31.2 15752
5 ex32-1.htm EX-32.1 7359
6 ex32-2.htm EX-32.2 6966
  Complete submission text file 0001493152-16-009861.txt   4385817

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE imnp-20151231.xml EX-101.INS 569664
8 XBRL SCHEMA FILE imnp-20151231.xsd EX-101.SCH 58996
9 XBRL CALCULATION FILE imnp-20151231_cal.xml EX-101.CAL 51758
10 XBRL DEFINITION FILE imnp-20151231_def.xml EX-101.DEF 135993
11 XBRL LABEL FILE imnp-20151231_lab.xml EX-101.LAB 334815
12 XBRL PRESENTATION FILE imnp-20151231_pre.xml EX-101.PRE 237852
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54933 | Film No.: 161652890
SIC: 2834 Pharmaceutical Preparations